Opinion|Videos|September 16, 2024
Managing Adverse Events and Supportive Care Measures in CLL Treatment
The discussion covers proactive strategies and interventions for managing adverse events before dose modification and explores supportive care measures for chronic lymphocytic leukemia treatments, including variations based on specific Bruton tyrosine kinase inhibitors.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What proactive strategies and interventions are used to manage adverse events before resorting to dose modification?
- What supportive care measures are typically implemented to manage adverse events in chronic lymphocytic leukemia treatments and do these vary based on the specific Bruton tyrosine kinase inhibitor?
Advertisement
Related to this article
The randomized ALLIANCE A051701 trial closed early when treatment-related toxicity and mortality were increased without improving PFS in patients with newly diagnosed double-hit lymphoma.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Robin Tumlinson, PharmD, BCOP, discusses how rapidly expanding bladder cancer options are creating new questions around treatment sequencing, toxicity management, biomarker testing, and multidisciplinary care.
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
A prospective observational study found microplastics more frequently and at higher levels in lung samples from patients with lung malignancies, although the findings do not establish that the particles cause cancer.
Helicobacter pylori exposure could be associated with approximately 22% of colorectal cancer cases worldwide.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
2
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
3
Pharmacists' Role as Ketone Monitoring Reaches Clinics
4
Bladder Cancer Treatment Is Advancing Faster Than Answers on Sequencing and Toxicity Management
5